Eprosartan

Eprosartan, sold under the brand name Teveten among others, is an angiotensin II receptor antagonist used for the treatment of high blood pressure.
Eprosartan is sometimes paired with hydrochlorothiazide.
As with other angiotensin II receptor antagonists, eprosartan is generally better tolerated than enalapril, especially among the elderly.

History

The compound came into the Abbott Laboratories cardiovascular pipeline with its acquisition of Kos Pharmaceuticals in 2006, which had licensed it, along with "a range of hypertensive treatments", from the Biovail Corporation.